Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Nemus Bioscience (NMUS)

Nemus Bioscience (NMUS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 87,040
  • Shares Outstanding, K 133,908
  • Annual Sales, $ 0 K
  • Annual Income, $ -19,190 K
  • 60-Month Beta -0.04
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade NMUS with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.09
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 10/05/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4000 +62.50%
on 03/11/19
0.7440 -12.63%
on 03/21/19
+0.1550 (+31.31%)
since 02/22/19
3-Month
0.3000 +116.67%
on 01/31/19
0.7440 -12.63%
on 03/21/19
+0.2501 (+62.54%)
since 12/21/18
52-Week
0.0500 +1,200.00%
on 10/31/18
0.7440 -12.63%
on 03/21/19
+0.4098 (+170.61%)
since 03/22/18

Most Recent Stories

More News
Glaucoma Drugs Market Size | Global Industry Analysis and Opportunity Assessment 2021-2027

The latest research report on delivers a comprehensive study on current market trends. The outcome also includes revenue forecasts, statistics, market valuations which illustrate its growth trends and...

AERI : 19.18 (+4.30%)
AGN : 193.02 (+0.02%)
ITEK : 3.04 (-5.00%)
MRK : 72.38 (-0.33%)
NMUS : 0.6500 (-9.52%)
NVS : 87.45 (+1.79%)
OCAT : 8.47 (+0.12%)
OCUL : 19.46 (+6.11%)
OHRP : 5.39 (+30.19%)
PRGO : 42.26 (+4.71%)
PFE : 33.69 (+0.60%)
SNPHF : 14.1000 (+3.68%)
SCMP : 18.05 (+0.28%)
TEVA : 10.92 (+1.49%)
VRX.TO : 30.80 (-3.33%)
US Glaucoma Drugs Market Size 2021 By Trends Evaluation, Business Opportunities, Consumption, Growth Rate, Top Manufacturer, New Project Investment, Regional Analysis and Forecast to 2027

AI Market Report is working on a new report title Global Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2027? Rise in prevalence of eye disorders such as Presbyopia, Macular Degeneration...

AGN : 193.02 (+0.02%)
ITEK : 3.04 (-5.00%)
MRK : 72.38 (-0.33%)
NMUS : 0.6500 (-9.52%)
NVS : 87.45 (+1.79%)
OCAT : 8.47 (+0.12%)
OCUL : 19.46 (+6.11%)
OHRP : 5.39 (+30.19%)
PRGO : 42.26 (+4.71%)
PFE : 33.69 (+0.60%)
SNPHF : 14.1000 (+3.68%)
SCMP : 18.05 (+0.28%)
TEVA : 10.92 (+1.49%)
VRX.TO : 30.80 (-3.33%)
Educative: Can Businesses recover from COVID-19 impact in Glaucoma Drugs Market

A recent report on provides a detailed analysis on the industry size, revenue forecasts and geographical landscape pertaining to this business space. Additionally, the report highlights primary obstacles...

AERI : 19.18 (+4.30%)
AGN : 193.02 (+0.02%)
ITEK : 3.04 (-5.00%)
MRK : 72.38 (-0.33%)
NMUS : 0.6500 (-9.52%)
NVS : 87.45 (+1.79%)
OCAT : 8.47 (+0.12%)
OCUL : 19.46 (+6.11%)
OHRP : 5.39 (+30.19%)
PRGO : 42.26 (+4.71%)
PFE : 33.69 (+0.60%)
SNPHF : 14.1000 (+3.68%)
SCMP : 18.05 (+0.28%)
TEVA : 10.92 (+1.49%)
VRX.TO : 30.80 (-3.33%)
Glaucoma Drugs Market Opportunities, Demands and Growth Revenue by 2025 | Brandessence Market Research Report

AERI : 19.18 (+4.30%)
AGN : 193.02 (+0.02%)
CANF : 2.02 (-0.98%)
ITEK : 3.04 (-5.00%)
MRK : 72.38 (-0.33%)
NMUS : 0.6500 (-9.52%)
NVS : 87.45 (+1.79%)
OCAT : 8.47 (+0.12%)
OCUL : 19.46 (+6.11%)
OHRP : 5.39 (+30.19%)
PRGO : 42.26 (+4.71%)
PFE : 33.69 (+0.60%)
SNPHF : 14.1000 (+3.68%)
SCMP : 18.05 (+0.28%)
TEVA : 10.92 (+1.49%)
VRX.TO : 30.80 (-3.33%)
Europe Glaucoma Drugs Market Share, Size, Future Demand, Application, Top Leading Player, Upcoming Trends, Region By Forecast To 2025

A research report on features a succinct analysis on the latest market trends. The report also includes detailed abstracts about statistics, revenue forecasts and market valuation, which additionally...

AERI : 19.18 (+4.30%)
AGN : 193.02 (+0.02%)
CANF : 2.02 (-0.98%)
ITEK : 3.04 (-5.00%)
MRK : 72.38 (-0.33%)
NMUS : 0.6500 (-9.52%)
NVS : 87.45 (+1.79%)
OCAT : 8.47 (+0.12%)
OCUL : 19.46 (+6.11%)
OHRP : 5.39 (+30.19%)
PRGO : 42.26 (+4.71%)
PFE : 33.69 (+0.60%)
SNPHF : 14.1000 (+3.68%)
SCMP : 18.05 (+0.28%)
TEVA : 10.92 (+1.49%)
VRX.TO : 30.80 (-3.33%)
Glaucoma Drugs Market 2019 Top Key Players are Aerie Pharmaceuticals, Allergan plc, Bausch & Lomb Incorporated, Inotek Pharmaceuticals, Merck & Co. Inc., Pfizer Inc., Merck & Co., and Forecast to 2025

: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2018-2024?.Rise in prevalence of eye disorders such as Presbyopia, Macular Degeneration and Diabetic Retinopathy in the aging population...

AERI : 19.18 (+4.30%)
AGN : 193.02 (+0.02%)
ITEK : 3.04 (-5.00%)
MRK : 72.38 (-0.33%)
NMUS : 0.6500 (-9.52%)
NVS : 87.45 (+1.79%)
OCAT : 8.47 (+0.12%)
OCUL : 19.46 (+6.11%)
OHRP : 5.39 (+30.19%)
PRGO : 42.26 (+4.71%)
PFE : 33.69 (+0.60%)
SNPHF : 14.1000 (+3.68%)
SCMP : 18.05 (+0.28%)
TEVA : 10.92 (+1.49%)
VRX.TO : 30.80 (-3.33%)
Nemus Bioscience, Inc. Changes Name to Emerald Bioscience, Inc. and Provides Update of Recent Research Accomplishments

NMUS : 0.6500 (-9.52%)
EMBI : 0.0900 (+1.69%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 0.7752
1st Resistance Point 0.7126
Last Price 0.6500
1st Support Level 0.5937
2nd Support Level 0.5374
3rd Support Level N/A

See More

52-Week High 0.7440
Last Price 0.6500
Fibonacci 61.8% 0.4789
Fibonacci 50% 0.3970
Fibonacci 38.2% 0.3151
52-Week Low 0.0500

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar